Status:
UNKNOWN
Artificial Intelligence for Diminutive Polyp Characterization
Lead Sponsor:
Hospital Universitario La Fe
Collaborating Sponsors:
European Society of Gastrointestinal Endoscopy
Medtronic
Conditions:
Colorectal Neoplasms
Eligibility:
All Genders
Phase:
NA
Brief Summary
Artificial intelligence is a promising tool that may have a role in characterizing colon epithelial lesions (CADx), helping to get a reliable optical diagnosis regardless of the endoscopist experience...
Detailed Description
The resect-and-discard (R\&D) and diagnose-and-leave (D\&L) strategies have been proposed as a means to reduce costs in the evaluation of colorectal polyps avoiding a substantial number of pathology e...
Eligibility Criteria
Inclusion
- Patients attending a colonoscopy within a population-based CRC screening program (FIT- or colonoscopy-based) or because of post-polypectomy surveillance,
- Written informed consent before the colonoscopy,
Exclusion
- None, patient included
- Previous history of inflammatory bowel disease.
- Previous history of CRC
- Previous CR resection
- Polyposis or hereditary CRC syndrome
- Coagulopathy/Anticoagulants
- Unwillingness to participate
Key Trial Info
Start Date :
February 27 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2024
Estimated Enrollment :
643 Patients enrolled
Trial Details
Trial ID
NCT05391477
Start Date
February 27 2023
End Date
December 1 2024
Last Update
May 31 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Universitari i Politècnic La Fe
Valencia, Spain, 46026